Limit or avoid consumption of alcohol when taking Abilify. Warnings Dementia: People who take Abilify may experience an increased risk of death if they have dementia-related psychosis Abilify is not approved for elderly populations with dementia-related psychosis.
ABILIFY ASIMTUFII and ABILIFY MAINTENA increase the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are
ABILIFY MAINTENA is not approved for the treatment of patients with dementia-related psychosis. ABILIFY MAINTENA is contraindicated with a known
dementia (which is the loss of memory and other mental abilities). ABILIFY MAINTENA is not to be used if you are elderly and have dementia.
ABILIFY ASIMTUFII and ABILIFY MAINTENA increase the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis.
ABILIFY ASIMTUFII and ABILIFY MAINTENA increase the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are
loss (dementia). ABILIFY ASIMTUFII and ABILIFY MAINTENA are not aripiprazole of elderly people with dementia-related psychosis and can lead to death.
Abilify is not approved for the treatment of dementia-related psychosis. Some individuals with dementia may, however, be treated with this medication. Discuss
Abilify, also known as aripiprazole, is a treatment Increased mortality in elderly patients with dementia-related psychosis: Abilify
Comments